Ocean Biomedical Inc (OCEA)
0.9207
-0.07
(-6.99%)
USD |
NASDAQ |
Sep 20, 16:00
0.9207
0.00 (0.00%)
After-Hours: 20:00
Ocean Biomedical Shareholders Equity (Quarterly): -75.22M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -75.22M |
| June 30, 2023 | -8.401M |
| March 31, 2023 | 1.544M |
| December 31, 2022 | 104.30M |
| Date | Value |
|---|---|
| June 30, 2022 | -9.537M |
| September 30, 2021 | -3.027M |
| March 31, 2021 | -2.095M |
| December 31, 2020 | -1.885M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-75.22M
Minimum
Sep 2023
104.30M
Maximum
Dec 2022
0.7091M
Average
-2.561M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.031M |
| Total Liabilities (Quarterly) | 76.26M |